Seminar Banner

NKI Seminar by Michael Murphy

Mitochondrial superoxide formation during ischemia-reperfusion injury

Friday 2 June 2023 11:00 - 12:00 Piet Borst Auditorium Seminar

Michael Murphy

MRC-Mitochondrial Biology Unit, University of Cambridge, UK

Host: Marc de Gooijer

Mike Murphy’s research focuses on the roles of reactive oxygen species in mitochondrial function and pathology. In particular he has pioneered the targeting of bioactive and probe molecules to mitochondria in vivo. This general methodology is now widely used. Prominent mitochondria-targeted compounds are antioxidants, such as MitoQ, which protects against oxidative damage in ischaemia-reperfusion injury. Murphy and Rob Smith developed MitoQ as an oral drug which has been used in two Phase II trials so far. This work established mitochondria as a relevant drug target and opened up the field of mitochondrial pharmacology.

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.